Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
ASTRAZEN
₹7,150.50
₹7137.50
₹7214.00
₹7110.00
₹9849.50
Markets Today
Historical Performance
As of 26-08-2026 22:29, AstraZeneca Pharma India Ltd. share price today is ₹0, with a change of ₹-7146.00 (-100.00%) from the previous close of ₹7146. The stock opened at ₹7190 and traded between ₹7137.5 and ₹7214, with a total traded volume of 3427 shares. The company has a market capitalization of ₹17865 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹9849.5 and ₹7110, respectively.
AstraZeneca Pharma India Ltd. valuation metrics include a P/E ratio of 105.3, and book value of ₹19.60. Profitability indicators show ROE of 21.48% along with a dividend yield of 0.5%. AstraZeneca Pharma India Ltd. has reported revenue of ₹2432.06 Cr and net profit of ₹169.62 Cr.
AstraZeneca Pharma India Ltd. technical indicators include Day RSI at 21.97, Day MFI at 1.02, Day ADX at 29.15. Additional indicators include Commodity Channel Index (CCI) at -166.2 and Williams %R at -96.87. Momentum indicators show Day MACD at -229.73, Day MACD Signal Line at -156.5, DayATR at 199.7. Rate of Change indicators for AstraZeneca Pharma India Ltd. include ROC125 at -19.73 and ROC21 at -12.51.
Exponential moving averages include EMA5 at ₹7343.3, EMA10 at ₹7518, EMA12 at ₹7570.9, EMA20 at ₹7722.6, EMA26 at ₹7800.6, EMA50 at ₹7992.7, EMA100 at ₹8194.1, EMA200 at ₹8348.4. Simple moving averages include SMA5 at ₹7360.2, SMA10 at ₹7553.8, SMA20 at ₹7842, SMA30 at ₹7915.6, SMA50 at ₹8073.6, SMA100 at ₹8244, SMA150 at ₹8356.7, SMA200 at ₹8508.5.
Support levels for AstraZeneca Pharma are placed at First Support ₹7079.00, Second Support ₹7012.00, Third Support ₹6914.00. Resistance levels are seen at First Resistance ₹7244.00, Second Resistance ₹7342.00, Third Resistance ₹7409.00. AstraZeneca Pharma India Ltd. shareholding pattern shows promoter holding at 75%, FII holding at 2.68%, DII holding at 0%, public holding at 16.24%.
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 682.79 | 578.61 | 611.57 | 559.09 | 526.31 |
| Operating Expense | 633.85 | 517.70 | 566.74 | 483.91 | 445.20 |
| Operating Profit | 48.94 | 60.91 | 44.83 | 75.18 | 81.11 |
| Depreciation | 5.23 | 5.60 | 3.84 | 2.57 | 16.57 |
| Interest | 1.95 | 2.04 | 1.06 | 0.67 | 0.72 |
| Tax | 12.82 | 13.26 | 13.95 | 18.60 | 18.87 |
| Net Profit | 37.93 | 44.88 | 32.59 | 54.22 | 55.83 |
₹7150.50
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 2.9 | 3 | 2.7 | 2.7 | 2.8 | 2.7 |
| DII | 4.6 | 4.6 | 5.3 | 5.6 | 5.8 | 6.1 |
| Public | 17.4 | 17.4 | 17 | 16.7 | 16.4 | 16.2 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 10.75 K | 16.08 K | 66.87% |
| Week | 22.83 K | 30.79 K | 74.14% |
| 1 Month | 14.38 K | 20.15 K | 71.38% |
| 6 Month | 6.33 K | 11.23 K | 56.36% |
Companies with no Debt
Benjamin Graham Value Screen
Growth Stars: Strongest Annual EPS Performers
Expensive Performers (DVM)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 31 Jul, 2026 | 36 | FINAL | 31 Jul, 2026 | Equity Share |
| 18 Jul, 2025 | 32 | FINAL | 18 Jul, 2025 | Equity Share |
| 05 Jul, 2024 | 24 | FINAL | 05 Jul, 2024 | Equity Share |
| 14 Jul, 2023 | 16 | FINAL | 14 Jul, 2023 | Equity Share |
| 07 Jul, 2022 | 8 | FINAL | 08 Jul, 2022 | Equity Share |
| 18 Aug, 2021 | 2 | INTERIM | 20 Aug, 2021 | Equity Share |
| 20 Aug, 2020 | 2 | INTERIM | 21 Aug, 2020 | Equity Share |
| 20 Aug, 2019 | 1 | INTERIM | 21 Aug, 2019 | Equity Share |
| 09 Jul, 2012 | 3.5 | FINAL | Equity Share | |
| 07 Jul, 2011 | 10 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹2,105.20 | ₹1,121.20 | ₹1,490.20 | ₹1,488.20 | ₹4,175 | ₹766.10 |
| % Change | 0.38% | -0.53% | 0.66% | -1.84% | -0.05% | 2.83% |
| Revenue TTM (₹ Cr) | ₹1,479.07 | ₹675.61 | ₹691.72 | ₹1,543.34 | ₹949.80 | ₹4,501.61 |
| Net Profit TTM (₹ Cr) | ₹199.03 | ₹182.64 | ₹126.37 | ₹-48.62 | ₹266 | ₹291.72 |
| PE TTM | 64.40 | 69.70 | 54.00 | -357.60 | 36.20 | 40.20 |
| 1 Year Return | 97.49 | 90.08 | 106.23 | -19.51 | -19.2 | 55.75 |
| ROCE | 31.54 | 24.22 | 15.60 | 0.59 | - | 11.40 |
Innova Captab Ltd.
₹ 1020.60
-1.90%
Blue Jet Healthcare Ltd
₹ 590.85
+0.29%
Concord Biotech Ltd.
₹ 1546.10
-0.12%
Aarti Pharmalabs Ltd.
₹ 839.00
+0.49%
Supriya Lifescience Ltd.
₹ 784.00
-0.97%
Alivus Life Sciences Ltd.
₹ 1365.00
+1.23%
Cohance Lifesciences Ltd.
₹ 462.00
+3.73%
Eris Lifesciences Ltd.
₹ 1312.90
+0.25%
Syngene International Ltd.
₹ 410.40
+0.98%
Alembic Pharmaceuticals Ltd.
₹ 826.40
+2.90%
Sun Pharma Advanced Research Company Ltd.
₹ 194.70
+0.12%
Strides Pharma Science Ltd.
₹ 983.50
-0.31%
FDC Ltd.
₹ 347.65
+1.16%
Shilpa Medicare Ltd.
₹ 860.00
-0.18%
Jubilant Pharmova Ltd.
₹ 886.05
-1.18%
Natco Pharma Ltd.
₹ 864.60
-0.19%
Caplin Point Laboratories Ltd.
₹ 2525.00
+2.15%
Marksans Pharma Ltd.
₹ 330.75
+3.85%
Orchid Pharma Ltd.
₹ 973.00
-6.31%
IOL Chemicals and Pharmaceuticals Ltd.
₹ 186.48
+8.19%
Viyash Scientific Ltd.
₹ 263.30
-5.41%
Bliss GVS Pharma Ltd.
₹ 573.70
+2.17%
Sanofi India Ltd.
₹ 3190.00
-0.26%
Morepen Laboratories Ltd.
₹ 97.89
+4.25%
By signing up I certify terms, conditions & privacy policy